Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries-Reference-Cited by-同舟云学术

Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries

Published:2012-01 Issue:1 Volume:23 Page:127-134
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Corbo V.,Beghelli S.,Bersani S.,Antonello D.,Talamini G.,Brunelli M.,Capelli P.,Falconi M.,Scarpa A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/1/127/13785930/mdr048.pdf

Reference60 articles.

1. Update on the molecular pathogenesis of pancreatic tumors other than common ductal adenocarcinoma;Antonello;Pancreatology,2009

2. Endocrine neoplasms of the pancreas: pathologic and genetic features;Capelli;Arch Pathol Lab Med,2009

3. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases;Corbo;Endocr Relat Cancer,2010

4. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification;Kloppel;Ann N Y Acad Sci,2004

5. Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas;Bettini;Dig Liver Dis,2009

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Молекулярный профиль нейроэндокринных опухолей;Malignant tumours;2022-11-18

2. Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translation;Frontiers in Oncology;2022-09-28

3. Novel therapeutic approaches in GEP-NETs based on genetic and epigenetic alterations;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-09

4. Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumors display divergent genomic and transcriptomic profiles;Expert Opinion on Therapeutic Targets;2021-12-02

5. Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis;CJC Open;2021-11